PyInvesting

Market research

RGS.AU Regeneus Ltd

Latest close

Loading market data…

Test a moving-average rule with historical data.

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Regeneus Ltd is currently in a long term downtrend where the price is trading 36.1% below its 200 day moving average.

From a valuation standpoint, the stock is 98.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.

Regeneus Ltd's total revenue rose by 905930.8% to $7M since the same quarter in the previous year.

Its net income has increased by 458.9% to $4M since the same quarter in the previous year.

Finally, its free cash flow grew by 303.5% to $2M since the same quarter in the previous year.

Based on the above factors, Regeneus Ltd gets an overall score of 4/5.